Literature DB >> 20171891

Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists.

Karina L Bienfait1, Matthew Menza, Margery H Mark, Roseanne D Dobkin.   

Abstract

Impulse control disorders, including pathological gambling, binge eating, compulsive shopping and hypersexual behaviors, have frequently been reported as a side effect of dopaminergic medications for Parkinson's disease (PD). Here we describe a patient with PD who developed an unusual manifestation of impulsive behaviors, including cigarette smoking, associated with an increase in dopamine agonist medication. We postulate this to be related to an overstimulation of mesolimbic dopamine receptors responsible for reward-seeking behaviors. Further research is needed to examine impulsive cigarette smoking in PD. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171891      PMCID: PMC2834808          DOI: 10.1016/j.jocn.2009.09.001

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  The relationship between impulsivity and impulse control disorders in Parkinson's disease.

Authors:  Ioannis U Isaias; Chiara Siri; Roberto Cilia; Danilo De Gaspari; Gianni Pezzoli; Angelo Antonini
Journal:  Mov Disord       Date:  2008-02-15       Impact factor: 10.338

2.  Long-term follow-up of impulse control disorders in Parkinson's disease.

Authors:  Eugenia Mamikonyan; Andrew D Siderowf; John E Duda; Marc N Potenza; Stacy Horn; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-01       Impact factor: 10.338

Review 3.  Medication-related impulse control and repetitive behaviors in Parkinson's disease.

Authors:  Valerie Voon; Marc N Potenza; Teri Thomsen
Journal:  Curr Opin Neurol       Date:  2007-08       Impact factor: 5.710

Review 4.  Impulse control and related disorders in Parkinson's disease: review.

Authors:  Shen-Yang Lim; Andrew H Evans; Janis M Miyasaki
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

5.  Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.

Authors:  Arthur L Brody; Mark A Mandelkern; Richard E Olmstead; David Scheibal; Emily Hahn; Sharon Shiraga; Eleanor Zamora-Paja; Judah Farahi; Sanjaya Saxena; Edythe D London; James T McCracken
Journal:  Arch Gen Psychiatry       Date:  2006-07

6.  Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis.

Authors:  I I Kessler; E L Diamond
Journal:  Am J Epidemiol       Date:  1971-07       Impact factor: 4.897

7.  Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Authors:  Daniel Weintraub; Andrew D Siderowf; Marc N Potenza; Joseph Goveas; Knashawn H Morales; John E Duda; Paul J Moberg; Matthew B Stern
Journal:  Arch Neurol       Date:  2006-07

8.  Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Authors:  Valerie Voon; Teri Thomsen; Janis M Miyasaki; Minella de Souza; Ariel Shafro; Susan H Fox; Sarah Duff-Canning; Anthony E Lang; Mateusz Zurowski
Journal:  Arch Neurol       Date:  2007-02

Review 9.  Parkinson's disease-related disorders in the impulsive-compulsive spectrum.

Authors:  Eric Ch Wolters; Ysbrand D van der Werf; Odile A van den Heuvel
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

  9 in total
  12 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

Review 2.  Impulsive and compulsive behaviors in Parkinson's disease.

Authors:  B B Averbeck; S S O'Sullivan; A Djamshidian
Journal:  Annu Rev Clin Psychol       Date:  2013-12-02       Impact factor: 18.561

Review 3.  Impulse control disorders in Parkinson's disease: recent advances.

Authors:  Valerie Voon; Arpan R Mehta; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

4.  Effects of the 5HT2C antagonist SB242084 on the pramipexole-induced potentiation of water contrafreeloading, a putative animal model of compulsive behavior.

Authors:  Chiara Schepisi; Lorenza De Carolis; Paolo Nencini
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

Review 5.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

Review 6.  Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.

Authors:  Roberto Cilia; Thilo van Eimeren
Journal:  Brain Struct Funct       Date:  2011-05-04       Impact factor: 3.270

7.  Diagnosis and treatment of impulse control disorders in patients with movement disorders.

Authors:  Tiago A Mestre; Antonio P Strafella; Teri Thomsen; Valerie Voon; Janis Miyasaki
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

8.  Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson's disease.

Authors:  Andrew D Lawrence; David J Brooks; Alan L Whone
Journal:  Front Psychol       Date:  2013-02-27

Review 9.  Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's Disease.

Authors:  Atbin Djamshidian; Werner Poewe; Birgit Högl
Journal:  Parkinsons Dis       Date:  2015-11-18

10.  A conditioned response as a measure of impulsive-compulsive behaviours in Parkinson's disease.

Authors:  Andrew H Evans; Jade Kettlewell; Sarah McGregor; Katya Kotschet; Robert I Griffiths; Malcolm Horne
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.